Nasogastric Tubes for Bronchiolitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This study aims to evaluate whether placing nasogastric tubes for gastric decompression improves respiratory distress for patients with bronchiolitis who are receiving oxygen via high-flow nasal cannula.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is it safe to use nasogastric tubes in humans?
Nasogastric tubes are generally safe for delivering nutrition and medication, but incorrect placement can lead to serious complications like pneumothorax (air in the chest cavity) or hemothorax (blood in the chest cavity). Proper training and verification of tube placement are crucial to avoid these risks.12345
How does nasogastric tube placement differ from other treatments for bronchiolitis?
Nasogastric tube placement is unique for bronchiolitis as it provides nutrition directly to the stomach when oral feeding is not possible, unlike other treatments that may focus on respiratory support. It is commonly used in children during the bronchiolitis season, especially in hospitals, to ensure they receive adequate nutrition while recovering.16789
What data supports the effectiveness of the treatment Nasogastric tube placement for bronchiolitis?
While there is no direct evidence for using nasogastric tubes specifically for bronchiolitis, nasogastric tubes are commonly used for feeding in children with feeding difficulties and have been shown to be an effective method for providing nutrition. They are also used in various medical settings to ensure patients receive necessary nutrients when they cannot eat by mouth.110111213
Who Is on the Research Team?
David Spiro, MD, MPH
Principal Investigator
AR Children's Hospital
Are You a Good Fit for This Trial?
This trial is for babies and toddlers up to 23 months old with bronchiolitis who are receiving oxygen through a high-flow nasal cannula. It's not suitable for those with tracheostomy, short gut syndrome, congenital heart disease, G-tube dependence, cranio-facial anomalies or bacterial pneumonia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nasogastric tube placement for gastric decompression while on high-flow nasal cannula
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nasogastric tube placement
Nasogastric tube placement is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Bowel obstruction
- Ileus
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Gastric decompression
- Nutritional support
- Medication administration
- Gastric decompression
- Nutritional support
- Gastric decompression
- Nutritional support
- Medication administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arkansas Children's Hospital Research Institute
Lead Sponsor